Host tissues and immune system

The host tissues and immune system represent the integrated biological framework of an organism, encompassing all cellular structures and the specialized defense mechanisms that maintain homeostasis and protect against pathogens (National Institute of Allergy and Infectious Diseases, 2020). This entity is not a single molecular target but rather a complex network of cells, such as lymphocytes and myeloid cells, and organs like the thymus and bone marrow, which coordinate to distinguish self from non-self (Janeway et al., 2001). In clinical pharmacology, therapeutic agents are typically designed to target specific molecular components within this system—such as cytokines (e.g., TNF-alpha), cell surface receptors (e.g., CD20), or intracellular signaling molecules (e.g., JAK kinases)—to treat conditions like autoimmune diseases, chronic inflammation, and cancer (Abbas et al., 2014). Because this entry encompasses the entire physiological landscape of the host, it is classified as a systemic category rather than a discrete, druggable molecule. Consequently, drugs interacting with this "target" often have broad effects, requiring a careful balance between therapeutic efficacy and the risk of systemic side effects like immunosuppression or cytokine release syndrome (StatPearls, 2023).

Other names

Host immune systemHost environmentSystemic immunityHost-pathogen interface

Systemic modulation of immune signaling pathways, cellular recruitment, and inflammatory cascades to restore homeostasis or eliminate pathogens.